Tempus Pixel vs Cleerly ISCHEMIA
AI Verdict
Choose Tempus Pixel if…
Choose Tempus Pixel if your institution requires a versatile, multi-specialty AI imaging platform to enhance diagnostic accuracy and workflow efficiency across a broad range of modalities, including MRI, CT, X-ray, and ultrasound. This tool is ideal for departments seeking real-time collaboration, automated reporting, and advanced 3D visualization capabilities for cardiology, oncology, and neurology cases.
View Tempus Pixel →Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if your primary focus is on the precise, non-invasive assessment of coronary artery disease and the likelihood of ischemia using CCTA scans. This tool is specifically designed for cardiologists and imaging centers needing detailed vessel-level ischemia determination, coronary plaque characterization, and non-invasive fractional flow reserve (FFR) estimation to guide personalized treatment plans for heart disease patients.
View Cleerly ISCHEMIA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus Pixel | Cleerly ISCHEMIA |
|---|---|---|
| Pricing | Contact for quote | Contact for details |
| Deployment | Cloud-based, web-based (accessible via Google Chrome browser), integrates with existing PACS, EHR, and RIS environments. | Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus PixelTempus Pixel offers multi-modality support (MRI, CT, X-ray, ultrasound) and explicitly mentions real-time collaboration, suggesting a broader and more versatile platform for various imaging types and team workflows. While both are web-based and integrate with existing systems, Tempus Pixel's wider applicability across imaging modalities likely enhances its overall usability for a diverse clinical environment.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA provides a highly specific and deeply validated clinical value proposition in non-invasive ischemia detection and comprehensive plaque characterization from CCTA. It has demonstrated superior diagnostic accuracy and prognostic utility in multiple clinical trials, including the ability to predict future major adverse cardiovascular events (MACE).
Pricing & Value
Cleerly ISCHEMIAWhile neither tool offers transparent pricing, Cleerly ISCHEMIA has a significant advantage by being billable under specific Category I CPT codes (75580 for FFR estimation and 75577 for plaque analysis). This indicates established reimbursement pathways and a recognized value proposition within the healthcare system, providing a clearer financial model for providers.
Enterprise Readiness
Cleerly ISCHEMIABoth tools are FDA-cleared, HIPAA compliant, and integrate with existing hospital systems. However, Cleerly ISCHEMIA explicitly states it has a Business Associate Agreement (BAA) and has addressed cybersecurity in accordance with FDA guidance. Furthermore, its substantial growth in scan volume and referring providers in 2023 demonstrates robust real-world adoption and scalability.
Innovation
Cleerly ISCHEMIACleerly ISCHEMIA's specialized focus on non-invasive FFR estimation and comprehensive plaque characterization from CCTA, offering a '3-in-1 approach' to redefine heart disease diagnosis, is highly innovative. This has been recognized through multiple industry awards, including 'Best Overall AI Solution' and 'Best Use of AI in Health Tech'.
Support & Docs
Tempus PixelTempus Pixel provides more detailed and transparent information regarding its customer support channels, including phone, email, and live chat, along with specified business hours and guaranteed response times for urgent requests. Cleerly ISCHEMIA offers client support but without the same level of detail on availability or response commitments.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus Pixel | Cleerly ISCHEMIA |
|---|---|---|
| Name | Tempus Pixel | Cleerly ISCHEMIA |
| Company | Tempus (formerly Arterys) | Cleerly |
| Tagline | The future of precision medicine that only human + AI can achieve. | AI-Powered Precision for Non-Invasive Ischemia Detection |
| Primary Application/Focus | Enhances diagnostic accuracy and workflow efficiency for radiologists and clinicians across cardiology, oncology, and neurology. | Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. |
| Supported Modalities | Multi-modality support (MRI, CT, X-ray, ultrasound) | CCTA scans |
| Specific Analysis Capabilities | AI-powered analysis, Automated reporting, 3D visualization, Quantitative analysis, Real-time collaboration, DICOM compatibility. | AI-enabled CCTA analysis, Non-invasive fractional flow reserve (FFR) estimation, Vessel-level ischemia likelihood determination, Coronary plaque characterization (volume, type, location), Stenosis severity assessment, 3D digital models of coronary arteries, Comprehensive interactive web-based reports. |
Videos
Demos, reviews, and walkthroughs featuring Tempus Pixel and Cleerly ISCHEMIA.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus Pixel or Cleerly ISCHEMIA
Backers
Who funded each tool's parent company.